Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs Combined NRT for Smoking Cessation and Rescue Treatment
NCT02271919Phase 4Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2015
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Group I (varenicline and placebo) with Group II (placebo, nicotine patch and lozenge) (2 arms). Primary endpoint: Smoking Abstinence at 12 weeks. Started May 2015; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02271919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271919.